Literature DB >> 7468761

The relationship of blood vessel proximity and time after radiolabeled thymidine administration to tumor cell population kinetics in a transplanted mouse mammary tumor.

Z P Pavelic, L M Allen, E Mihich.   

Abstract

The relation between the time of administration of tritiated thymidine and the proximity of cells to blood vessels and their labeling index, grain density per labeled cells, mitotic index, and growth fraction have been determined autoradiographically in a transplanted mammary tumor of mice. The tumor was rich in blood vessels, and the cells were densely packed, showing a few glandular structures. Shortly after tritiated thymidine administration, cells closer to the blood vessels (0-70 mu) showed a higher percentage of labeled and mitotic cells, more grains per labeled cells, and a higher growth fraction than the cells located in the outer zone (70-140 mu). Eight days later the values of these parameters were similar in both areas. The cell cycle time, the duration of mitosis, the S phase, the G1 phase and the G2 phase were essentially the same in both zones. These results could be attributed either to reutilization of nucleic acid metabolites or release of the original precursor from cells. It is suggested that label redistribution, which may perturb the measurement of the apparent turnover of labeled proliferating cellular systems in the body should be considered in all cases of autoradiographic or labeled purine-pyrimidine turnover studies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7468761      PMCID: PMC1903433     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  The utilization in vivo of mouse nucleic acid metabolites labeled with radioactive precursor substances.

Authors:  M R SCHWARZ; W O RIEKE
Journal:  Lab Invest       Date:  1963-01       Impact factor: 5.662

2.  RNA mediation in DNA synthesis in HeLa cells studied with tritium labeled cytidine and thymidine.

Authors:  L E FEINENDEGEN; V P BOND; W L HUGHES
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

3.  Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse. I. Typical cell cycle and timing of DNA synthesis.

Authors:  M L MENDELSOHN; F C DOHAN; H A MOORE
Journal:  J Natl Cancer Inst       Date:  1960-09       Impact factor: 13.506

4.  Turnover of nuclear and cytoplasmic ribonucleic acid in two types of animal cell, with some further observations on the nucleolus.

Authors:  H HARRIS
Journal:  Biochem J       Date:  1959-10       Impact factor: 3.857

5.  Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse. III. The growth fraction.

Authors:  M L MENDELSOHN
Journal:  J Natl Cancer Inst       Date:  1962-05       Impact factor: 13.506

6.  The labelled mitoses curve and the estimation of the parameters of the cell cycle.

Authors:  C W Gilbert
Journal:  Cell Tissue Kinet       Date:  1972-01

7.  Kinetic parameters and growth curves for experimental tumor systems.

Authors:  L Simpson-Herren; H H Lloyd
Journal:  Cancer Chemother Rep       Date:  1970-06

8.  Kinetics of cell proliferation of an experimental tumor.

Authors:  E Frindel; E P Malaise; E Alpen; M Tubiana
Journal:  Cancer Res       Date:  1967-06       Impact factor: 12.701

9.  LIFE CYCLE ANALYSIS OF MAMMALIAN CELLS. II. CELLS FROM THE CHINESE HAMSTER OVARY GROWN IN SUSPENSION CULTURE.

Authors:  T T PUCK; P SANDERS; D PETERSEN
Journal:  Biophys J       Date:  1964-11       Impact factor: 4.033

10.  The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.

Authors:  I F Tannock
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640

View more
  1 in total

1.  Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence.

Authors:  K S Lee; T Hoshino; L A Rodriguez; J Bederson; R L Davis; C B Wilson
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.